Foresite Capital Management VI LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Foresite Capital Management VI LLC held in its portfolio 12 assets valued at $330,838,998 (i.e. $330.84M).

The most valuable assets in the portfolio included: CG Oncology, Inc. ($92.24M), RAPT Therapeutics, Inc. ($52.92M), and ALUMIS INC. ($41.46M).

The chart below shows the top 10 valuable assets, and the table below shows the top 12 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Foresite Capital Management VI LLC Portfolio

CG Oncology, Inc.

RAPT Therapeutics, Inc.

ALUMIS INC.

Centessa Pharmaceuticals plc

Verastem, Inc.

Denali Therapeutics Inc.

Natera, Inc.

AGIOS PHARMACEUTICALS, INC.

Kymera Therapeutics, Inc.

Atai Beckley N.V.

Foresite Capital Management VI LLC - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
CG Oncology, Inc.	2221474	92235600	COM
RAPT Therapeutics, Inc.	1562500	52921875	COM
ALUMIS INC.	4247670	41457259	COM
Centessa Pharmaceuticals plc	1364019	34114115	SPONSORED ADS
Verastem, Inc.	3135120	24203126	COM
Denali Therapeutics Inc.	1000000	16510000	COM
Natera, Inc.	67356	15430586	COM
AGIOS PHARMACEUTICALS, INC.	530000	14426600	COM
Kymera Therapeutics, Inc.	146332	11386093	COM
Atai Beckley N.V.	2750000	11247500	SHS
Corvus Pharmaceuticals, Inc.	1381233	10635494	COM
Hinge Health, Inc.	135000	6270750	CL A